We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

7% more funds holding

Funds holding: 174 → 187 (+13)

3% less capital invested

Capital invested by funds: $802M → $774M (-$28M)

76% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $16.4M

Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$17.7M
2
PP
PDT Partners
New York
+$5.47M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.45M
4
TAM
Tocqueville Asset Management
New York
+$4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$25.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$21.7M
3
GAM
Gotham Asset Management
New York
-$6.87M
4
State Street
State Street
Massachusetts
-$6.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
76
Nationwide Fund Advisors
Ohio
$941K -$30.7K -1,646 -3%
Wells Fargo
77
Wells Fargo
California
$941K +$56.1K +3,010 +6%
CS
78
Credit Suisse
Switzerland
$936K -$349K -18,717 -27%
Federated Hermes
79
Federated Hermes
Pennsylvania
$921K +$283K +15,171 +44%
LS
80
Livforsakringsbolaget Skandia
Sweden
$915K – – –
ERSOT
81
Employees Retirement System of Texas
Texas
$886K +$261K +14,000 +41%
Canada Life
82
Canada Life
Manitoba, Canada
$869K – – –
State Board of Administration of Florida Retirement System
83
State Board of Administration of Florida Retirement System
Florida
$850K +$417K +22,374 +94%
FMBTD
84
First Midwest Bank Trust Division
Illinois
$809K +$817K +43,844 New
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
$755K – – –
SO
86
STRS Ohio
Ohio
$743K -$26.1K -1,400 -3%
First Trust Advisors
87
First Trust Advisors
Illinois
$735K +$743K +39,843 New
IIM
88
Ironwood Investment Management
Massachusetts
$708K +$75 +4 +0%
CAM
89
ClariVest Asset Management
California
$703K +$16.8K +900 +2%
Nordea Investment Management
90
Nordea Investment Management
Sweden
$703K +$16.8K +900 +2%
MCM
91
Matarin Capital Management
New York
$666K -$6.32K -339 -0.9%
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
$656K -$39.8K -2,135 -6%
AA
93
ALPS Advisors
Colorado
$641K +$58.1K +3,119 +10%
SAM
94
Shell Asset Management
Netherlands
$636K +$643K +34,493 New
Comerica Bank
95
Comerica Bank
Texas
$586K +$8.42K +452 +1%
Two Sigma Investments
96
Two Sigma Investments
New York
$567K +$573K +30,745 New
State of Tennessee, Department of Treasury
97
State of Tennessee, Department of Treasury
Tennessee
$544K -$34.7K -1,862 -6%
AIG
98
American International Group
New York
$513K +$28.7K +1,540 +6%
ADEF
99
Adams Diversified Equity Fund
Maryland
$511K -$18.6K -1,000 -3%
Two Sigma Advisers
100
Two Sigma Advisers
New York
$504K +$177K +9,500 +53%
2 3
4
5 6

AMAG Hedge Fund Activity: Q3 2017 in Review

187 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2017, worth a combined $774M — down 3.5% from $802M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMAG positions and 20 closed out — a net gain of 15 holders — while 68 added to existing stakes and 54 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $25.5M.

  • 187 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $774M of AMAG Pharmaceuticals stock for Q3 2017, down 3.5% quarter-over-quarter.
  • 35 funds opened new AMAG Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +15 holders.
  • The largest AMAG Pharmaceuticals buyer in Q3 2017 was Camber Capital Management, an estimated $17.7M added.
  • The largest AMAG Pharmaceuticals seller in Q3 2017 was Invesco, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2017.